Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
NGS
Small RNA biomarkers in cancer: how NGS is revolutionizing miRNA-based research.
May 1, 2025 -
6 min read
NGS
Exploring long noncoding RNAs: structure, function, biomarker potential and sequencing considerations.
April 25, 2025 -
4 min read
NGS
SPRI technology: principles, bead composition, and bead-to-sample ratio impact.
December 4, 2024 -
2 min read
NGS
The Evolution of agrigenomics: From microarrays to next-generation sequencing.
November 21, 2024 -
4 min read
NGS, Disease Research
Hot topics in genomics: What to watch for at ASHG 2024.
October 25, 2024 -
2 min read
NGS, Cancer, Biomarker Detection
Why are miRNAs promising non-invasive Biomarkers?
October 23, 2024 -
5 min read
NGS
Navigating the complexities of miRNA sequencing data analysis.
October 11, 2024 -
3 min read
